Powles, Thomas
Eder, Joseph Paul
Fine, Gregg D.
Braiteh, Fadi S.
Loriot, Yohann
Cruz, Cristina
Bellmunt, Joaquim
Burris, Howard A.
Petrylak, Daniel P.
Teng, Siew-leng
Shen, Xiaodong
Boyd, Zachary
Hegde, Priti S.
Chen, Daniel S.
Vogelzang, Nicholas J.
Article History
Received: 23 May 2014
Accepted: 30 September 2014
First Online: 26 November 2014
Competing interests
: T.P., consultant/advisory for GlaxoSmithKline, Genentech; F.S.B., speaker and advisory for Inctye; consultant/advisory for BMS; Research funding from Roche; Y.L., Research grants from Astellas, Sanofi; consultant for Astellas, Sanofi, Cellgen, Pierre Fabre; J.B., uncompensated consultant/advisory for Genentech; N.J.V., consultant to Roche/Genentech; G.D.F., S.-l.T., X.S., Z.B., P.S.H. and D.S.C. are employees of Genentech. C.C., D.P.P., H.A.B. and J.P.E. have no disclosures.